Brief: Aura Biosciences Q3 Operating Expenses USD 20.488 Million
09/11/2023 21:05
Nov 09 (Reuters) - Aura Biosciences Q3 net income USD -18.512 million. * Q3 operating income USD -20.488 million
Recent news on Aura Biosciences
See all newsBrief: Aura Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Aura Biosciences - May Offer Securities Up To $500 Million Aggregate
Brief: Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Aura Biosciences Q1 net loss widens on higher R&D costs